CN102697928B - Preparation method for medicine composition for treating traumatic injury - Google Patents
Preparation method for medicine composition for treating traumatic injury Download PDFInfo
- Publication number
- CN102697928B CN102697928B CN201210197567.3A CN201210197567A CN102697928B CN 102697928 B CN102697928 B CN 102697928B CN 201210197567 A CN201210197567 A CN 201210197567A CN 102697928 B CN102697928 B CN 102697928B
- Authority
- CN
- China
- Prior art keywords
- weight portions
- weight
- parts
- radix
- radix angelicae
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000003814 drug Substances 0.000 title claims abstract description 59
- 238000002360 preparation method Methods 0.000 title claims abstract description 23
- 208000014674 injury Diseases 0.000 title claims abstract description 11
- 230000008736 traumatic injury Effects 0.000 title claims abstract description 9
- 239000000203 mixture Substances 0.000 title abstract description 20
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 36
- 239000004863 Frankincense Substances 0.000 claims abstract description 27
- 229940079593 drug Drugs 0.000 claims abstract description 24
- 239000007788 liquid Substances 0.000 claims abstract description 16
- 239000000843 powder Substances 0.000 claims abstract description 9
- 230000004087 circulation Effects 0.000 claims abstract description 6
- 238000010438 heat treatment Methods 0.000 claims abstract description 6
- 241000717739 Boswellia sacra Species 0.000 claims description 26
- 241001057584 Myrrha Species 0.000 claims description 26
- 235000003143 Panax notoginseng Nutrition 0.000 claims description 26
- 241000180649 Panax notoginseng Species 0.000 claims description 26
- 241001604597 Pyrestini Species 0.000 claims description 26
- 239000008194 pharmaceutical composition Substances 0.000 claims description 20
- 238000000034 method Methods 0.000 claims description 13
- 238000007598 dipping method Methods 0.000 claims description 5
- 239000012530 fluid Substances 0.000 claims description 5
- 239000011812 mixed powder Substances 0.000 claims description 5
- 239000012467 final product Substances 0.000 claims description 4
- 241000382455 Angelica sinensis Species 0.000 abstract 1
- 235000003717 Boswellia sacra Nutrition 0.000 abstract 1
- 240000007551 Boswellia serrata Species 0.000 abstract 1
- 235000012035 Boswellia serrata Nutrition 0.000 abstract 1
- 240000007311 Commiphora myrrha Species 0.000 abstract 1
- 235000006965 Commiphora myrrha Nutrition 0.000 abstract 1
- 244000301850 Cupressus sempervirens Species 0.000 abstract 1
- 244000070010 Erythrina variegata Species 0.000 abstract 1
- 235000007265 Myrrhis odorata Nutrition 0.000 abstract 1
- 244000131316 Panax pseudoginseng Species 0.000 abstract 1
- 235000003181 Panax pseudoginseng Nutrition 0.000 abstract 1
- 238000011049 filling Methods 0.000 abstract 1
- 238000001914 filtration Methods 0.000 abstract 1
- 244000237330 gutta percha tree Species 0.000 abstract 1
- 238000002156 mixing Methods 0.000 abstract 1
- 230000001105 regulatory effect Effects 0.000 abstract 1
- 238000002791 soaking Methods 0.000 abstract 1
- 208000002193 Pain Diseases 0.000 description 12
- 239000002671 adjuvant Substances 0.000 description 11
- 230000036407 pain Effects 0.000 description 11
- 239000008280 blood Substances 0.000 description 9
- 210000004369 blood Anatomy 0.000 description 9
- 230000000694 effects Effects 0.000 description 7
- 239000006187 pill Substances 0.000 description 7
- 238000011282 treatment Methods 0.000 description 7
- 208000027418 Wounds and injury Diseases 0.000 description 6
- 230000017531 blood circulation Effects 0.000 description 6
- 208000026137 Soft tissue injury Diseases 0.000 description 5
- 230000001737 promoting effect Effects 0.000 description 5
- 208000034656 Contusions Diseases 0.000 description 4
- 206010052428 Wound Diseases 0.000 description 4
- 230000001154 acute effect Effects 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 229940040145 liniment Drugs 0.000 description 4
- 239000000865 liniment Substances 0.000 description 4
- 239000012567 medical material Substances 0.000 description 4
- 229920000742 Cotton Polymers 0.000 description 3
- 239000000443 aerosol Substances 0.000 description 3
- 208000034526 bruise Diseases 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 235000012907 honey Nutrition 0.000 description 3
- 210000001503 joint Anatomy 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 239000007921 spray Substances 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 208000032843 Hemorrhage Diseases 0.000 description 2
- 206010024453 Ligament sprain Diseases 0.000 description 2
- 206010053615 Thermal burn Diseases 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- -1 cataplasma Substances 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 238000005469 granulation Methods 0.000 description 2
- 230000003179 granulation Effects 0.000 description 2
- 238000011835 investigation Methods 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 239000000825 pharmaceutical preparation Substances 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 210000002435 tendon Anatomy 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 208000006820 Arthralgia Diseases 0.000 description 1
- 241000208365 Celastraceae Species 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 206010014080 Ecchymosis Diseases 0.000 description 1
- 208000032912 Local swelling Diseases 0.000 description 1
- 235000000336 Solanum dulcamara Nutrition 0.000 description 1
- 208000010040 Sprains and Strains Diseases 0.000 description 1
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 210000000544 articulatio talocruralis Anatomy 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000003797 carpal joint Anatomy 0.000 description 1
- 230000009519 contusion Effects 0.000 description 1
- 239000003405 delayed action preparation Substances 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 239000006196 drop Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 239000007902 hard capsule Substances 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 238000011221 initial treatment Methods 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 229940074869 marquis Drugs 0.000 description 1
- 235000015091 medicinal tea Nutrition 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 230000000399 orthopedic effect Effects 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 238000000554 physical therapy Methods 0.000 description 1
- VBUNOIXRZNJNAD-UHFFFAOYSA-N ponazuril Chemical compound CC1=CC(N2C(N(C)C(=O)NC2=O)=O)=CC=C1OC1=CC=C(S(=O)(=O)C(F)(F)F)C=C1 VBUNOIXRZNJNAD-UHFFFAOYSA-N 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 210000000323 shoulder joint Anatomy 0.000 description 1
- 239000002893 slag Substances 0.000 description 1
- 239000007901 soft capsule Substances 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 229940098465 tincture Drugs 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a preparation method for a medicine composition for treating traumatic injury. The medicine composition for treating the traumatic injury comprises the following crude drugs in parts by weight: 8-28 parts of pseudo-ginseng, 4-14 parts of angelica sinensis, 4-14 parts of myrrh, 4-14 parts of eucommia ulmoides, 4-14 parts of rhizoma cibotii, 4-14 parts of herba lycopi, 4-14 parts of notopterygium root, 4-14 parts of radix angelicae pubescentis, 4-14 parts of golden cypress, 4-14 parts of erythrina indica lam and 4-14 parts of fried frankincense. The preparation method for the medicine composition for treating the traumatic injury comprises the following steps of mixing and crushing the eleven crude drugs into a coarse powder; adding 800 parts of alcohol (55 percent) in parts by weight and soaking for 12-48 hours; then, heating a liquid medicine and keeping the temperature of the liquid medicine at 30-40 DEG C; performing forced circulation for 3.5 hours; filtering to obtain an alcohol extract; regulating the alcohol extract by using alcohol to enable the alcohol content of the alcohol extract to be 53-57 percent; and performing separate filling when the total content reaches 700 parts by weight to obtain the medicine composition for treating the traumatic injury.
Description
Technical field
The present invention relates to a kind of pharmaceutical composition and preparation thereof, preparation method, be specifically related to a kind of pharmaceutical composition for the treatment of traumatic injury and preparation thereof, preparation method, belong to pharmaceutical technology field.
Background technology
Acute soft tissue injury is orthopedics department commonly encountered diseases, frequently-occurring disease, belongs to the traditional Chinese medical science " injury of tendon and muscle " category, and clinical main manifestations is local swelling, pain, dysfunction, livid purple ecchymosis etc.Modern medicine has wrapping, partial closure, physical therapy etc. to the primary treatment method of acute soft tissue injury, and these method curative effects are not good enough, and rehabilitation duration is longer.The traditional Chinese medical science thinks that the main pathogenesis of acute soft tissue injury is that qi depression to blood stasis, venation are obstructed, in treatment, has unique advantage.
Summary of the invention
The object of the invention is to provide a kind of pharmaceutical composition and preparation thereof for the treatment of traumatic injury, and second object of the present invention is to provide the preparation method of this pharmaceutical composition,
The present invention seeks to be achieved through the following technical solutions.
The crude drug of pharmaceutical composition of the present invention consists of:
Radix Notoginseng 8-28 weight portion, Radix Angelicae Sinensis 4-14 weight portion, Myrrha 4-14 weight portion, Cortex Eucommiae 4-14 weight portion, Rhizoma Cibotii 4-14 weight portion, Herba Lycopi 4-14 weight portion, Rhizoma Et Radix Notopterygii 4-14 weight portion, Radix Angelicae Pubescentis 4-14 weight portion, Cortex Phellodendri 4-14 weight portion, Cortex erythrinae 4-14 weight portion, Olibanum (parched) 4-14 weight portion.
The crude drug composition of pharmaceutical composition of the present invention is preferably:
Radix Notoginseng 18 weight portions, Radix Angelicae Sinensis 9 weight portions, Myrrha 9 weight portions, the Cortex Eucommiae 9 weight portions, Rhizoma Cibotii 9 weight portions, Herba Lycopi's 9 weight portions, Rhizoma Et Radix Notopterygii 9 weight portions, Radix Angelicae Pubescentis 9 weight portions, Cortex Phellodendri 9 weight portions, Cortex erythrinae 9 weight portions, Olibanum (parched) 9 weight portions.
The crude drug composition of pharmaceutical composition of the present invention is preferably:
Radix Notoginseng 10 weight portions, Radix Angelicae Sinensis 13 weight portions, Myrrha 5 weight portions, the Cortex Eucommiae 13 weight portions, Rhizoma Cibotii 5 weight portions, Herba Lycopi's 13 weight portions, Rhizoma Et Radix Notopterygii 5 weight portions, Radix Angelicae Pubescentis 13 weight portions, Cortex Phellodendri 5 weight portions, Cortex erythrinae 13 weight portions, Olibanum (parched) 5 weight portions.
The crude drug composition of pharmaceutical composition of the present invention is preferably:
Radix Notoginseng 13 weight portions, Radix Angelicae Sinensis 11 weight portions, Myrrha 6 weight portions, the Cortex Eucommiae 11 weight portions, Rhizoma Cibotii 6 weight portions, Herba Lycopi's 11 weight portions, Rhizoma Et Radix Notopterygii 6 weight portions, Radix Angelicae Pubescentis 11 weight portions, Cortex Phellodendri 6 weight portions, Cortex erythrinae 11 weight portions, Olibanum (parched) 6 weight portions.
The crude drug composition of pharmaceutical composition of the present invention is preferably:
Radix Notoginseng 16 weight portions, Radix Angelicae Sinensis 10 weight portions, Myrrha 8 weight portions, the Cortex Eucommiae 10 weight portions, Rhizoma Cibotii 8 weight portions, Herba Lycopi's 10 weight portions, Rhizoma Et Radix Notopterygii 8 weight portions, Radix Angelicae Pubescentis 10 weight portions, Cortex Phellodendri 8 weight portions, Cortex erythrinae 10 weight portions, Olibanum (parched) 8 weight portions.
The crude drug composition of pharmaceutical composition of the present invention is preferably:
Radix Notoginseng 20 weight portions, Radix Angelicae Sinensis 8 weight portions, Myrrha 10 weight portions, the Cortex Eucommiae 8 weight portions, Rhizoma Cibotii 10 weight portions, Herba Lycopi's 8 weight portions, Rhizoma Et Radix Notopterygii 10 weight portions, Radix Angelicae Pubescentis 8 weight portions, Cortex Phellodendri 10 weight portions, Cortex erythrinae 8 weight portions, Olibanum (parched) 10 weight portions.
The crude drug composition of pharmaceutical composition of the present invention is preferably:
Radix Notoginseng 23 weight portions, Radix Angelicae Sinensis 7 weight portions, Myrrha 11 weight portions, the Cortex Eucommiae 7 weight portions, Rhizoma Cibotii 11 weight portions, Herba Lycopi's 7 weight portions, Rhizoma Et Radix Notopterygii 11 weight portions, Radix Angelicae Pubescentis 7 weight portions, Cortex Phellodendri 11 weight portions, Cortex erythrinae 7 weight portions, Olibanum (parched) 11 weight portions.
The crude drug composition of pharmaceutical composition of the present invention is preferably:
Radix Notoginseng 26 weight portions, Radix Angelicae Sinensis 5 weight portions, Myrrha 13 weight portions, the Cortex Eucommiae 5 weight portions, Rhizoma Cibotii 13 weight portions, Herba Lycopi's 5 weight portions, Rhizoma Et Radix Notopterygii 13 weight portions, Radix Angelicae Pubescentis 5 weight portions, Cortex Phellodendri 13 weight portions, Cortex erythrinae 5 weight portions, Olibanum (parched) 13 weight portions.
Chinese medicine composition of the present invention adds conventional adjuvant, according to common process, makes clinical acceptable various preparations and includes but not limited to: external preparation is as aerosol, ointment, cataplasma, liniment, rubber-emplastrum, paste, liniment, transdermal patch etc.; Oral formulations is as powder, tablet, medicinal tea, hard capsule, soft capsule, drop pill, pill, honeyed pill, granule, soft extract with bee honey agent, medicated wine, oral liquid or ejection preparation and slow releasing preparation, controlled release preparation or quick releasing formulation etc.
The preparation method of Chinese medicine composition of the present invention comprises the steps:
Above 11 taste medical materials, mixed powder is broken into coarse powder, add behind 55% alcohol dipping 12-48 hour of 600 weight portions, it is 30 ℃～40 ℃ that medicine liquid heating is kept to fluid temperature, forced circulation 3.5 hours, filter, obtain alcohol extract, making alcohol extract contain alcohol amount with ethanol adjustment is 53%～57%, and total amount reaches 540 weight portions, subpackage, to obtain final product.
The sweet micro-bitter temperature of Radix Notoginseng in Chinese medicine composition composition formula of the present invention, removing stasis to stop bleeding, the analgesic therapy of invigorating blood circulation, is the key medicine of blood circulation promoting and blood stasis dispelling, therefore be monarch drug.Radix Angelicae Sinensis Gan Xinwen, enriches blood, invigorates blood circulation, and pain relieving, and make blood circulation promoting and blood stasis dispelling and non-blood trouble; Olibanum, the pain relieving of Myrrha blood-activating and qi-promoting, detumescence and promoting granulation, three medicines are ministerial drug altogether.Herba Lycopi's toil tepor, blood circulation promoting and blood stasis dispelling; The sweet temperature of the Cortex Eucommiae, invigorating the liver and kidney, bone and muscle strengthening; The bitter sweet temperature of Rhizoma Cibotii, wind-damp dispelling, invigorating the liver and kidney, strong waist knee joint; Rhizoma Et Radix Notopterygii, the arduous temperature of Radix Angelicae Pubescentis, wind-damp dispelling, stopping numbness pain; Cortex erythrinae toil is flat, wind-damp dispelling, removing obstruction in the collateral to relieve pain; Cortex Phellodendri bitter cold, heat clearing and damp drying, eliminating fire and detoxication, is adjuvant drug.All medicines share, and play altogether the merit that blood circulation promoting and blood stasis dispelling, reducing swelling and alleviating pain, relaxing muscles and tendons and activating QI and blood in the collateral, hemostasis are cured the wound.Curing mainly various new and old soft tissue injurys, wound, scald, traumatic hemorrhage, Fengshi Guanjie swells and ache.
Following experimental example and embodiment are used for further illustrating but are not limited to the present invention.
experimental example 1 Chinese medicine composition clinical summary report of the present invention
1 physical data
Total case 60 examples, male 34 examples, female's 26 examples, 12～57 years old age, the course of disease 1 hour to 4 days.Wherein Ankle joint sprain and contusion 31 examples, shoulder joint bruise 12 examples, carpal joint bruise 17 examples.With reference to the diagnostic criteria about acute soft tissue injury in " new Chinese medicine guideline of clinical investigations ", make a definite diagnosis rear use Chinese medicine composition of the present invention (by embodiment 1 method preparation) and treat.
2 Therapeutic Method
Spraying affected part, gently rubs, and 3～4 times on the one 7 days is a course for the treatment of, after 1 course for the treatment of, judges curative effect.Inactive other drug during treatment.Coordinate and take medicine prepared by embodiment 10 if desired.
3 criterions of therapeutical effect
Judge with reference to the criterion of therapeutical effect in " new Chinese medicine guideline of clinical investigations ".Clinical cure: red, swollen, hot, pain disappears, and accompanying or adjacent joints activity freely; Effective: red, swollen, heat disappears, and slightly aches, accompanying or adjacent joints activity is substantially not limited; Effective: red, swollen, hot, alleviation of pain is light, accompanying or adjacent joints activity is slightly limited; Invalid: red, swollen, hot, pain nothing is improved, and joint motion is limited.
4 therapeutic outcomes
44 examples of fully recovering in 60 examples (73.3%), effective and effective 14 examples (23.3%), invalid 2 examples (3.3%), total effective rate 96.7%.
Following embodiment all can realize effect described in above-mentioned experimental example.
embodiment 1 tincture of the present invention
[formula]
[method for making]
Above 11 taste medical materials, mixed powder is broken into coarse powder, add 55% alcohol dipping of 600kg after 24 hours, it is 30 ℃～40 ℃ that medicine liquid heating is kept to fluid temperature, forced circulation 3.5 hours, filter, obtain alcohol extract, making alcohol extract contain alcohol amount with ethanol adjustment is 53%～57%, and total amount reaches 540kg, subpackage, to obtain final product.
[usage and consumption]
Knife injury, wound, scald, get injured by a fall, hemorrhage: directly spray liquid medicine in wound, after marquis's liquid medicine absorbs, wrap up with clean gauze.Spray heals for several times.
Osteopatia sprain: directly spray liquid medicine in affected part, gently rub and be aided with massage with absorbent cotton.
Dissipating blood stasis for subsidence of swelling: ooze liquid medicine with absorbent cotton and again and again spread on affected part, when bruise pain is serious, the hot compress in addition of available heat water bag, alleviating pain and detumescence effect is better.
Arthralgia: ooze liquid medicine with absorbent cotton and spread on affected part.
embodiment 2 aerosol of the present invention
Radix Notoginseng 10kg, Radix Angelicae Sinensis 13kg, Myrrha 5kg, Cortex Eucommiae 13kg, Rhizoma Cibotii 5kg, Herba Lycopi 13kg, Rhizoma Et Radix Notopterygii 5kg, Radix Angelicae Pubescentis 13kg, Cortex Phellodendri 5kg, Cortex erythrinae 13kg, Olibanum (parched) 5kg.
Above 11 taste medical materials, mixed powder is broken into coarse powder, add 55% alcohol dipping of 600kg after 48 hours, it is 30 ℃～40 ℃ that medicine liquid heating is kept to fluid temperature, forced circulation 3.5 hours, filter, obtain alcohol extract, making alcohol extract contain alcohol amount with ethanol adjustment is 53%～57%, and total amount reaches 540kg, add conventional adjuvant, make aerosol.External.
embodiment 3 liniment of the present invention
Radix Notoginseng 13kg, Radix Angelicae Sinensis 11kg, Myrrha 6kg, Cortex Eucommiae 11kg, Rhizoma Cibotii 6kg, Herba Lycopi 11kg, Rhizoma Et Radix Notopterygii 6kg, Radix Angelicae Pubescentis 11kg, Cortex Phellodendri 6kg, Cortex erythrinae 11kg, Olibanum (parched) 6kg.
Above 11 taste medical materials, mixed powder is broken into coarse powder, add 55% alcohol dipping of 600kg after 12 hours, it is 30 ℃～40 ℃ that medicine liquid heating is kept to fluid temperature, forced circulation 3.5 hours, filter, obtain alcohol extract, making alcohol extract contain alcohol amount with ethanol adjustment is 53%～57%, and total amount reaches 540kg, add conventional adjuvant, make liniment.External.
embodiment 4 transdermal patch of the present invention
Radix Notoginseng 16kg, Radix Angelicae Sinensis 10kg, Myrrha 8kg, Cortex Eucommiae 10kg, Rhizoma Cibotii 8kg, Herba Lycopi 10kg, Rhizoma Et Radix Notopterygii 8kg, Radix Angelicae Pubescentis 10kg, Cortex Phellodendri 8kg, Cortex erythrinae 10kg, Olibanum (parched) 8kg.
Said medicine is added to conventional adjuvant, according to common process, make transdermal patch.
embodiment 5 medicated wine of the present invention
Radix Notoginseng 26kg, Radix Angelicae Sinensis 5kg, Myrrha 13kg, Cortex Eucommiae 5kg, Rhizoma Cibotii 13kg, Herba Lycopi 5kg, Rhizoma Et Radix Notopterygii 13kg, Radix Angelicae Pubescentis 5kg, Cortex Phellodendri 13kg, Cortex erythrinae 5kg, Olibanum (parched) 13kg.
Above medicine soaks 48 hours with yellow wine, removes slag and gets liquid, to obtain final product.For oral administration.
embodiment 6 powder of the present invention
Radix Notoginseng 10kg, Radix Angelicae Sinensis 13kg, Myrrha 5kg, Cortex Eucommiae 13kg, Rhizoma Cibotii 5kg, Herba Lycopi 13kg, Rhizoma Et Radix Notopterygii 5kg, Radix Angelicae Pubescentis 13kg, Cortex Phellodendri 5kg, Cortex erythrinae 13kg, Olibanum (parched) 5kg.
Said medicine is added to conventional adjuvant, according to common process, make powder.
embodiment 7 capsule of the present invention
Radix Notoginseng 13kg, Radix Angelicae Sinensis 11kg, Myrrha 6kg, Cortex Eucommiae 11kg, Rhizoma Cibotii 6kg, Herba Lycopi 11kg, Rhizoma Et Radix Notopterygii 6kg, Radix Angelicae Pubescentis 11kg, Cortex Phellodendri 6kg, Cortex erythrinae 11kg, Olibanum (parched) 6kg.
Said medicine is added to conventional adjuvant, according to common process, make capsule.
embodiment 8 honey pill agent of the present invention
Radix Notoginseng 16kg, Radix Angelicae Sinensis 10kg, Myrrha 8kg, Cortex Eucommiae 10kg, Rhizoma Cibotii 8kg, Herba Lycopi 10kg, Rhizoma Et Radix Notopterygii 8kg, Radix Angelicae Pubescentis 10kg, Cortex Phellodendri 8kg, Cortex erythrinae 10kg, Olibanum (parched) 8kg.
Said medicine is added to conventional adjuvant, according to common process, make honey pill agent.
embodiment 9 granule of the present invention
Radix Notoginseng 20kg, Radix Angelicae Sinensis 8kg, Myrrha 10kg, Cortex Eucommiae 8kg, Rhizoma Cibotii 10kg, Herba Lycopi 8kg, Rhizoma Et Radix Notopterygii 10kg, Radix Angelicae Pubescentis 8kg, Cortex Phellodendri 10kg, Cortex erythrinae 8kg, Olibanum (parched) 10kg.
Said medicine is added to conventional adjuvant, according to common process, granulation agent.
embodiment 10 oral liquid of the present invention
Radix Notoginseng 23kg, Radix Angelicae Sinensis 7kg, Myrrha 11kg, Cortex Eucommiae 7kg, Rhizoma Cibotii 11kg, Herba Lycopi 7kg, Rhizoma Et Radix Notopterygii 11kg, Radix Angelicae Pubescentis 7kg, Cortex Phellodendri 11kg, Cortex erythrinae 7kg, Olibanum (parched) 11kg.
Said medicine is added to conventional adjuvant, according to common process, make oral liquid.
embodiment 11 drop pill of the present invention
Radix Notoginseng 26kg, Radix Angelicae Sinensis 5kg, Myrrha 13kg, Cortex Eucommiae 5kg, Rhizoma Cibotii 13kg, Herba Lycopi 5kg, Rhizoma Et Radix Notopterygii 13kg, Radix Angelicae Pubescentis 5kg, Cortex Phellodendri 13kg, Cortex erythrinae 5kg, Olibanum (parched) 13kg.
Said medicine is added to conventional adjuvant, according to common process, make drop pill.
Claims (7)
1. treat the preparation method of the pharmaceutical composition of traumatic injury for one kind, it is characterized in that the method is: get crude drug, mixed powder is broken into coarse powder, add 55% alcohol dipping of 800 weight portions after 24 hours, it is 35 ℃ that medicine liquid heating is kept to fluid temperature, forced circulation 3.5 hours, filters, and obtains alcohol extract, making alcohol extract contain alcohol amount with ethanol adjustment is 55%, total amount reaches 700 weight portions, and subpackage to obtain final product;
Described crude drug consists of: Radix Notoginseng 8-28 weight portion, Radix Angelicae Sinensis 4-14 weight portion, Myrrha 4-14 weight portion, Cortex Eucommiae 4-14 weight portion, Rhizoma Cibotii 4-14 weight portion, Herba Lycopi 4-14 weight portion, Rhizoma Et Radix Notopterygii 4-14 weight portion, Radix Angelicae Pubescentis 4-14 weight portion, Cortex Phellodendri 4-14 weight portion, Cortex erythrinae 4-14 weight portion, Olibanum (parched) 4-14 weight portion.
2. the preparation method of pharmaceutical composition as claimed in claim 1, is characterized in that consisting of of described crude drug:
Radix Notoginseng 10 weight portions, Radix Angelicae Sinensis 13 weight portions, Myrrha 5 weight portions, the Cortex Eucommiae 13 weight portions, Rhizoma Cibotii 5 weight portions, Herba Lycopi's 13 weight portions, Rhizoma Et Radix Notopterygii 5 weight portions, Radix Angelicae Pubescentis 13 weight portions, Cortex Phellodendri 5 weight portions, Cortex erythrinae 13 weight portions, Olibanum (parched) 5 weight portions.
3. the preparation method of pharmaceutical composition as claimed in claim 1, is characterized in that consisting of of described crude drug:
Radix Notoginseng 13 weight portions, Radix Angelicae Sinensis 11 weight portions, Myrrha 6 weight portions, the Cortex Eucommiae 11 weight portions, Rhizoma Cibotii 6 weight portions, Herba Lycopi's 11 weight portions, Rhizoma Et Radix Notopterygii 6 weight portions, Radix Angelicae Pubescentis 11 weight portions, Cortex Phellodendri 6 weight portions, Cortex erythrinae 11 weight portions, Olibanum (parched) 6 weight portions.
4. the preparation method of pharmaceutical composition as claimed in claim 1, is characterized in that consisting of of described crude drug:
Radix Notoginseng 16 weight portions, Radix Angelicae Sinensis 10 weight portions, Myrrha 8 weight portions, the Cortex Eucommiae 10 weight portions, Rhizoma Cibotii 8 weight portions, Herba Lycopi's 10 weight portions, Rhizoma Et Radix Notopterygii 8 weight portions, Radix Angelicae Pubescentis 10 weight portions, Cortex Phellodendri 8 weight portions, Cortex erythrinae 10 weight portions, Olibanum (parched) 8 weight portions.
5. the preparation method of pharmaceutical composition as claimed in claim 1, is characterized in that consisting of of described crude drug:
Radix Notoginseng 20 weight portions, Radix Angelicae Sinensis 8 weight portions, Myrrha 10 weight portions, the Cortex Eucommiae 8 weight portions, Rhizoma Cibotii 10 weight portions, Herba Lycopi's 8 weight portions, Rhizoma Et Radix Notopterygii 10 weight portions, Radix Angelicae Pubescentis 8 weight portions, Cortex Phellodendri 10 weight portions, Cortex erythrinae 8 weight portions, Olibanum (parched) 10 weight portions.
6. the preparation method of pharmaceutical composition as claimed in claim 1, is characterized in that consisting of of described crude drug:
Radix Notoginseng 23 weight portions, Radix Angelicae Sinensis 7 weight portions, Myrrha 11 weight portions, the Cortex Eucommiae 7 weight portions, Rhizoma Cibotii 11 weight portions, Herba Lycopi's 7 weight portions, Rhizoma Et Radix Notopterygii 11 weight portions, Radix Angelicae Pubescentis 7 weight portions, Cortex Phellodendri 11 weight portions, Cortex erythrinae 7 weight portions, Olibanum (parched) 11 weight portions.
7. the preparation method of pharmaceutical composition as claimed in claim 1, is characterized in that consisting of of described crude drug:
Radix Notoginseng 26 weight portions, Radix Angelicae Sinensis 5 weight portions, Myrrha 13 weight portions, the Cortex Eucommiae 5 weight portions, Rhizoma Cibotii 13 weight portions, Herba Lycopi's 5 weight portions, Rhizoma Et Radix Notopterygii 13 weight portions, Radix Angelicae Pubescentis 5 weight portions, Cortex Phellodendri 13 weight portions, Cortex erythrinae 5 weight portions, Olibanum (parched) 13 weight portions.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210197567.3A CN102697928B (en) | 2012-06-14 | 2012-06-14 | Preparation method for medicine composition for treating traumatic injury |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210197567.3A CN102697928B (en) | 2012-06-14 | 2012-06-14 | Preparation method for medicine composition for treating traumatic injury |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102697928A CN102697928A (en) | 2012-10-03 |
| CN102697928B true CN102697928B (en) | 2014-06-11 |
Family
ID=46891175
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201210197567.3A Active CN102697928B (en) | 2012-06-14 | 2012-06-14 | Preparation method for medicine composition for treating traumatic injury |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102697928B (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116270835A (en) * | 2023-01-08 | 2023-06-23 | 管为东 | Wound medicine and preparation method and equipment thereof |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN2292549Y (en) * | 1996-12-06 | 1998-09-30 | 鲁红秀 | Medical mattress |
| CN1319425A (en) * | 2001-02-23 | 2001-10-31 | 潘秋兰 | Medical preparation for stasis-eliminating and soothing sinew |
| CN101983652A (en) * | 2010-10-08 | 2011-03-09 | 黄岭 | Traditional Chinese medicine for treating scapulohumeral periarthritis |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4020992B2 (en) * | 1996-09-13 | 2007-12-12 | 帝國製薬株式会社 | A new saponin glycoside derived from Ginseng |
| KR100605114B1 (en) * | 2003-09-06 | 2006-07-28 | 주식회사 오스코텍 | Arthritis prevention and treatment composition containing Samchil root extract as an active ingredient |
-
2012
- 2012-06-14 CN CN201210197567.3A patent/CN102697928B/en active Active
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN2292549Y (en) * | 1996-12-06 | 1998-09-30 | 鲁红秀 | Medical mattress |
| CN1319425A (en) * | 2001-02-23 | 2001-10-31 | 潘秋兰 | Medical preparation for stasis-eliminating and soothing sinew |
| CN101983652A (en) * | 2010-10-08 | 2011-03-09 | 黄岭 | Traditional Chinese medicine for treating scapulohumeral periarthritis |
Non-Patent Citations (1)
| Title |
|---|
| 子叶叶1.漳州片仔癀跌打精.《百度百科，http://baike.baidu.com/view/3342370.htm》.2010, * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102697928A (en) | 2012-10-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101167847B (en) | Traditional Chinese medicinal white spirit preparation for effectively treating skin disease | |
| CN102247581B (en) | Medicament for treating myoma of uterus | |
| CN103055052B (en) | Cream for treating burn and scald and preparation method of cream | |
| CN101524450B (en) | Oral traditional Chinese medicine for setting bones and relieving rigidity of muscles and preparation method thereof | |
| CN104258278B (en) | Gushangling (for bone injury) spray | |
| CN103638237B (en) | External traumatic medicine composition, external traumatic medicinal oil and preparation method thereof | |
| CN103463580B (en) | Chinese medicine ointment for treating pain of muscles, bones and joints and preparation method thereof | |
| CN105056042A (en) | Medicinal liquor for treating traumatic injuries | |
| CN102716239A (en) | Pharmaceutical composite for treating traumatic injury | |
| CN106728615A (en) | Chinese medicine composition for synthetism life bone and preparation method thereof | |
| CN102697928B (en) | Preparation method for medicine composition for treating traumatic injury | |
| CN105106796A (en) | Traditional Chinese medicine composition for treating fracture and preparation method of traditional Chinese medicine composition | |
| CN103638116B (en) | A kind of auxiliary natural compound traditional Chinese medicine for bone setting | |
| CN104491828B (en) | A kind of temperature leads to Traditional Chinese medicine used as analgesic preparation and its paste preparation method | |
| CN108310070A (en) | A kind of Chinese medicine composition and preparation method thereof for treating pain | |
| CN102836306B (en) | Traditional Chinese medicine combination for treating horse traumatic injuries and preparation method of same | |
| CN106421255B (en) | External Chinese herbal medicine composition and application thereof | |
| CN102727636A (en) | Pharmaceutical composition preparation treating traumatic injuries | |
| CN104474405A (en) | Traditional Chinese medicine composition for treating chloasma | |
| CN110538272A (en) | swelling-reducing and collateral-dredging powder for treating soft tissue injury and joint swelling and pain and preparation method thereof | |
| CN104258113B (en) | A kind of Chinese medicine composition for the treatment of cerebral hemorrhage | |
| CN100478007C (en) | Plaster for treating traumatic injuries and rheumatism, and its prepn. method | |
| CN104971226A (en) | Traditional Chinese medicine for treating skin injuries and preparation method thereof | |
| CN105617214A (en) | Traditional Chinese medicine composition for treating scabies | |
| CN105853760A (en) | Orthopedic plaster and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CP02 | Change in the address of a patent holder |
Address after: 363000 No. 1, Amber Road, Xiangcheng District, Zhangzhou City, Fujian Province Patentee after: ZHANGZHOU PIEN TZE HUANG PHARMACEUTICAL Co.,Ltd. Address before: 363000, Fujian, Zhangzhou streets Patentee before: ZHANGZHOU PIEN TZE HUANG PHARMACEUTICAL Co.,Ltd. |
|
| CP02 | Change in the address of a patent holder |